Showing results (1851-1860 of 7,774) with videos related to
Sort By:
Pageof 778
Pharmacological Research|July 24, 2026
Targeting KLF4 degradation by doxycycline restores peroxisome lipid metabolism and mitochondrial energy production in acute kidney injuryJi Feng, Zhi-Sheng Yao, Yu-Hong Li, et al.Pharmacological Research|July 27, 2026
From multi-target to network synergy: A systematic review of how traditional Chinese medicine acts against myocardial ischemia-reperfusion injury via miRNA-mediated systemic communicationDe-Sheng Xu, Jiang-Xuan He, Jia-Hui Yan, et al.Pharmacological Research|July 20, 2026
The JAK1 inhibitor golidocitinib boosts therapeutic potency of DLL3-targeted CAR-T therapy for small cell lung cancerMengwei Li, Yao Zhang, Fangqi Li, et al.Pharmacological Research|October 2, 2020
Cholesterol homeostasis: Researching a dialogue between the brain and peripheral tissuesMicaela Gliozzi, Vincenzo Musolino, Francesca Bosco, et al.Pharmacological Research|August 27, 2020
Decoding the rosetta stone of mitonuclear communicationJustin English, Jyung Mean Son, Maria Dafne Cardamone, et al.Pharmacological Research|June 9, 2026
Mitochondrial vulnerability to aldehydic load and the role mitochondrial aldehyde dehydrogenasesTakuya Seike, Daria Mochly-RosenPharmacological Research|September 12, 2017
The emerging role of AMP-activated protein kinase in cholestatic liver diseasesXiaojiaoyang Li, Runping Liu, Luyong Zhang, et al.Pharmacological Research|July 1, 1989
Effect of various aminoglycoside antibiotics on glucose formation in isolated rabbit kidney-cortex tubulesM Michalik, S Głazewski, J BryłaPharmacological Research|August 6, 2026
A pathway-dependency framework for acquired resistance to targeted therapy in EGFR-mutant, KRAS G12C-mutant, and BRAF V600E-mutant NSCLCXiaoxiao Li, Yadong Guo, Shize YangPharmacological Research|August 7, 2026
Clinical utilities of platelet-derived growth factor signaling in breast cancerJesse J Reardon, Alexis A Mossing, Rebecca L Packard, et al.Pageof 778